Analysis of second opinion programs provided by German statutory and private health insurance - a survey of statutory and private health insurers

被引:5
|
作者
Koensgen, Nadja [1 ]
Prediger, Barbara [1 ]
Bora, Ana-Mihaela [1 ]
Glatt, Angelina [1 ]
Hess, Simone [1 ]
Weissflog, Victoria [2 ]
Pieper, Dawid [1 ]
机构
[1] Witten Herdecke Univ, Inst Res Operat Med, Cologne, Germany
[2] Medexo GmbH Med Experts Online, Berlin, Germany
关键词
Second opinion; Second opinion programs; Health insurance; Informed decision making; Patient autonomy; Survey; SEEKING; RATES;
D O I
10.1186/s12913-021-06207-8
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
BackgroundSecond medical opinions can give patients confidence when choosing among treatment options and help them understand their diagnosis. Health insurers in several countries, including Germany, offer formal second opinion programs (SecOPs). We systematically collected and analyzed information on German health insurers' approach to SecOPs, how the SecOPs are structured, and to what extent they are evaluated.MethodsIn April 2019, we sent a questionnaire by post to all German statutory (n =109) and private health insurers (n =52). In September 2019, we contacted the nonresponders by email. The results were analyzed descriptively. They are presented overall and grouped by type of insurance (statutory/private health insurer).ResultsThirty one of One hundred sixty one health insurers (response rate 19%) agreed to participate. The participating insurers covered approximately 40% of the statutory and 34% of the private health insured people. A total of 44 SecOPs were identified with a median of 1 SecOP (interquartile range (IQR) 1-2) offered by a health insurer. SecOPs were in place mainly for orthopedic (21/28 insurers with SecOPs; 75%) and oncologic indications (20/28; 71%). Indications were chosen principally based on their potential impact on a patient (22/28; 79%). The key qualification criterion for second opinion providers was their expertise (30/44 SecOPs; 68%).Second opinions were usually provided based on submitted documents only (21/44; 48%) or on direct contact between a patient and a doctor (20/44; 45%). They were delivered after a median of 9days (IQR 5-15). A median of 31 (IQR 7-85) insured persons per year used SecOPs. Only 12 of 44 SecOPs were confirmed to have conducted a formal evaluation process (27%) or, if not, plan such a process in the future (10/22; 45%).ConclusionHealth insurers' SecOPs focus on orthopedic and oncologic indications and are based on submitted documents or on direct patient-physician contact. The formal evaluation of SecOPs needs to be expanded and the results should be published. This can allow the evaluation of the impact of SecOPs on insured persons' health status and satisfaction, as well as on the number of interventions performed. Our results should be interpreted with caution due to the low participation rate.
引用
收藏
页数:10
相关论文
共 50 条
  • [41] Who is diagnosed as suffering from depression in the German statutory health care system? An analysis of health insurance data
    Bramesfeld, Anke
    Grobe, Thomas G.
    Schwartz, Friedrich Wilhelm
    [J]. EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2007, 22 (06) : 397 - 403
  • [42] Is the self-reported private health insurance status in the National Health Survey representative of private health insurance coverage in Australia?
    Ranmuthugala, Geetha
    Brown, Laurie
    Thurecht, Linc
    Lymer, Sharyn
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 2010, 34 (06) : 572 - 577
  • [43] INTERVENTIONAL RADIOLOGY AND THE NEW GERMAN STATUTORY HEALTH-INSURANCE AND HEALTH-CARE LEGISLATION
    THELEN, M
    [J]. FORTSCHRITTE AUF DEM GEBIETE DER RONTGENSTRAHLEN UND DER NEUEN BILDGEBENDEN VERFAHREN, 1995, 163 (01): : 1 - 3
  • [44] CUTANEOUS LYMPHOMAS IN GERMANY: LANDSCAPING ANALYSIS OF GERMAN STATUTORY HEALTH INSURANCE (SHI) CLAIMS DATA
    Doess, A.
    Jadasz, J.
    Zech, I. M.
    May, M.
    Feig, C.
    Hibbe, T.
    [J]. VALUE IN HEALTH, 2019, 22 : S735 - S735
  • [45] Health insurance for everyone? Private health insurers and the insurance of exceptional medical risks in the Netherlands 1900-2006
    Vonk, R.
    [J]. GESUNDHEITSWESEN, 2008, 70 (07) : 465 - 465
  • [46] Financial incentives in the German Statutory Health Insurance: New findings, new questions
    Stock, Stephanie
    Schmidt, Harald
    Buescher, Guido
    Gerber, Andreas
    Drabik, Anna
    Graf, Christian
    Luengen, Markus
    Stollenwerk, Bjoern
    [J]. HEALTH POLICY, 2010, 96 (01) : 51 - 56
  • [47] Advantages and Limitations of the DDD System in the Context of the German Statutory Health Insurance System
    Pfannkuche, M. S.
    Glaeske, G.
    Neye, H.
    Schoeffski, O.
    Hoffmann, F.
    [J]. GESUNDHEITSOEKONOMIE UND QUALITAETSMANAGEMENT, 2009, 14 (01): : 17 - 23
  • [48] Development of pharmaceutical expenses in German private health insurance
    Boecking, W.
    Tidelski, O.
    Skuras, B.
    Kitzmann, F.
    Zuehlke, L.
    [J]. DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2012, 137 (22) : 1201 - 1206
  • [49] Hypertension disease management in a German private health insurance
    Lickvers, K
    Kottmair, S
    Ziegenhagen, DJ
    Müller, M
    Middeke, M
    [J]. GESUNDHEITSWESEN, 2005, 67 (07) : 556 - 556